Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Reference38 articles.
1. Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366:397–408.
https://doi.org/10.1016/S0140-6736(05)67025-0
2. Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of Pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644.
https://doi.org/10.1200/JCO.2003.11.136
3. Hassan R, Cohen SJ, Phillips M et al (2010) Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers. Clin Cancer Res 16:6132–6138.
https://doi.org/10.1158/1078-0432.CCR-10-2275
4. Gralla RJ, Hollen PJ, Liepa AM, et al (2003) Improving quality of life in patients with malignant pleural mesothelioma: results of the randomized pemetrexed + cisplatin vs. cisplatin trial using the lcss-Meso instrument [abstract 2496] Proc Am Soc Clin Oncol 22
5. Leigh RA, Webster I (1982) Lymphocytic infiltration of pleural mesothelioma and its significance for survival. S Afr Med J 61:1007–1009
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献